Editorial: accumulating data about ustekinumab in refractory Crohn's disease in real world experience

Aliment Pharmacol Ther. 2017 May;45(10):1374-1375. doi: 10.1111/apt.14053.

Authors

S Khorrami¹, J P Gisbert²

Affiliations

¹ Department of Gastroenterology, Hospital Universitario Son Espases and Instituto de Investigación Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
² Department of Gastroenterology, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.

PMID: 28417496
DOI: 10.1111/apt.14053

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Crohn Disease*
Humans
Ustekinumab*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Ustekinumab